UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 314

Sortiert nach

Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection

Chest, 2018-01, Vol.153 (1), p.266-277

2018

Link zum Volltext

Verfügbarkeit prüfen

Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

The New England journal of medicine, 2014-03, Vol.370 (10), p.901-910

2014

Link zum Volltext

Verfügbarkeit prüfen

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Nature medicine, 2021-12, Vol.27 (12), p.2085-2098

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV

Nature communications, 2021-06, Vol.12 (1), p.3922-3922, Article 3922

2021

Link zum Volltext

Verfügbarkeit prüfen

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

The New England journal of medicine, 2015-08, Vol.373 (8), p.705-713

2015

Link zum Volltext

Verfügbarkeit prüfen

Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers

Clinical infectious diseases, 2010-10, Vol.51 (8), p.937-946

2010

Link zum Volltext

Verfügbarkeit prüfen

Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration

The Journal of infectious diseases, 2013-01, Vol.207 (2), p.213-222

2013

Link zum Volltext

Verfügbarkeit prüfen

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.581-589

2014

Link zum Volltext

Verfügbarkeit prüfen

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

The Journal of clinical investigation, 2023-09, Vol.133 (17), p.1-14

2023

Link zum Volltext

Verfügbarkeit prüfen

The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants

Antimicrobial agents and chemotherapy, 2021-11, Vol.65 (12), p.e0077221-e0077221

2021

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

Journal of acquired immune deficiency syndromes (1999), 2017-02, Vol.74 (2), p.193

2017

Link zum Volltext

Verfügbarkeit prüfen

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

AIDS (London), 2010-09, Vol.24 (14), p.2187-2192

2010

Link zum Volltext

Verfügbarkeit prüfen

Bone Disease and HIV Infection

Clinical infectious diseases, 2006-01, Vol.42 (1), p.108-114

2006

Link zum Volltext

Verfügbarkeit prüfen

The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health

PloS one, 2014-08, Vol.9 (8), p.e106221-e106221

2014

Link zum Volltext

Verfügbarkeit prüfen

Investigating hospital Mycobacterium chelonae infection using whole genome sequencing and hybrid assembly

PloS one, 2020-11, Vol.15 (11), p.e0236533-e0236533

2020

Link zum Volltext

Verfügbarkeit prüfen

Current use of statins reduces risk of HIV rebound on suppressive HAART

PloS one, 2017-03, Vol.12 (3), p.e0172175-e0172175

2017

Link zum Volltext

Verfügbarkeit prüfen

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

npj vaccines, 2021-10, Vol.6 (1), p.121-121, Article 121

2021

Link zum Volltext

Verfügbarkeit prüfen

Protective immunity by an engineered DNA vaccine for Mayaro virus

PLoS neglected tropical diseases, 2019-02, Vol.13 (2), p.e0007042-e0007042

2019

Link zum Volltext

Verfügbarkeit prüfen

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

PLoS neglected tropical diseases, 2020-10, Vol.14 (10), p.e0008788

2020

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Evolution of Bone Mineral Density and Bone Markers in Human Immunodeficiency Virus—Infected Individuals

Clinical infectious diseases, 2003-02, Vol.36 (4), p.482-490

2003

Link zum Volltext

Verfügbarkeit prüfen

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

AIDS (London), 2000-03, Vol.14 (4), p.F63-F67

2000

Link zum Volltext

Verfügbarkeit prüfen

Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States

HIV research & clinical practice, 2023-10, Vol.24 (1), p.2267825-2267825

2023

Link zum Volltext

Verfügbarkeit prüfen

Interferon-α alters host glycosylation machinery during treated HIV infection

EBioMedicine, 2020-09, Vol.59, p.102945-102945, Article 102945

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 314

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(256)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(225)
Science & Technology
(222)
Life Sciences & Biomedicine
(211)
Infectious Diseases
(163)
Male
(150)
Female
(141)
Hiv Infections - Drug Therapy
(134)
Adult
(132)
Immunology
(124)
Human Immunodeficiency Virus
(114)
Middle Aged
(114)
Hiv
(112)
Biological And Medical Sciences
(96)
Medical Sciences
(95)
Microbiology
(78)
Human Viral Diseases
(77)
Viral Diseases
(77)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(68)
Virology
(67)
Anti-Hiv Agents - Therapeutic Use
(62)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection

Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers

Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

Bone Disease and HIV Infection

The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health

Investigating hospital Mycobacterium chelonae infection using whole genome sequencing and hybrid assembly

Current use of statins reduces risk of HIV rebound on suppressive HAART

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

Protective immunity by an engineered DNA vaccine for Mayaro virus

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

Longitudinal Evolution of Bone Mineral Density and Bone Markers in Human Immunodeficiency Virus—Infected Individuals

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States

Interferon-α alters host glycosylation machinery during treated HIV infection

Suchergebnisse filtern